Prostatis Group LLC Acquires Shares of 10,094 Confluent, Inc. $CFLT

Prostatis Group LLC acquired a new stake in Confluent, Inc. (NASDAQ:CFLTFree Report) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 10,094 shares of the company’s stock, valued at approximately $252,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CFLT. GAMMA Investing LLC lifted its position in Confluent by 2,872.0% in the first quarter. GAMMA Investing LLC now owns 73,320 shares of the company’s stock valued at $1,719,000 after purchasing an additional 70,853 shares during the last quarter. SG Americas Securities LLC increased its stake in shares of Confluent by 25.8% during the first quarter. SG Americas Securities LLC now owns 26,884 shares of the company’s stock valued at $630,000 after buying an additional 5,520 shares during the period. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new position in shares of Confluent during the first quarter valued at approximately $259,000. Praxis Investment Management Inc. purchased a new position in shares of Confluent during the first quarter valued at approximately $213,000. Finally, Oppenheimer & Co. Inc. increased its stake in shares of Confluent by 1.5% during the first quarter. Oppenheimer & Co. Inc. now owns 92,432 shares of the company’s stock valued at $2,167,000 after buying an additional 1,370 shares during the period. Institutional investors own 78.09% of the company’s stock.

Insider Buying and Selling

In other news, CFO Rohan Sivaram sold 5,000 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $20.00, for a total value of $100,000.00. Following the sale, the chief financial officer directly owned 631,596 shares of the company’s stock, valued at approximately $12,631,920. This represents a 0.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Eric Vishria sold 30,953 shares of the stock in a transaction on Thursday, August 28th. The stock was sold at an average price of $20.00, for a total value of $619,060.00. Following the completion of the sale, the director directly owned 1,123,447 shares in the company, valued at approximately $22,468,940. This represents a 2.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 741,584 shares of company stock valued at $13,597,695 over the last 90 days. 13.82% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on CFLT shares. DA Davidson reduced their target price on Confluent from $32.00 to $24.00 and set a “buy” rating on the stock in a research note on Thursday, July 31st. Weiss Ratings reissued a “sell (e+)” rating on shares of Confluent in a research note on Wednesday, October 8th. Capital One Financial set a $21.00 target price on Confluent in a research note on Thursday, July 31st. Guggenheim reduced their target price on Confluent from $31.00 to $29.00 and set a “buy” rating on the stock in a research note on Thursday, July 31st. Finally, TD Cowen reissued a “hold” rating and set a $24.00 target price on shares of Confluent in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $27.43.

View Our Latest Research Report on Confluent

Confluent Price Performance

Shares of CFLT stock opened at $22.74 on Monday. The stock has a market cap of $7.84 billion, a price-to-earnings ratio of -24.19 and a beta of 0.96. The business’s fifty day moving average is $19.13 and its 200 day moving average is $21.75. Confluent, Inc. has a twelve month low of $15.64 and a twelve month high of $37.90. The company has a quick ratio of 3.98, a current ratio of 3.98 and a debt-to-equity ratio of 1.03.

Confluent (NASDAQ:CFLTGet Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.01. The company had revenue of $282.29 million for the quarter, compared to analysts’ expectations of $278.32 million. Confluent had a negative return on equity of 27.34% and a negative net margin of 29.27%.The firm’s revenue for the quarter was up 20.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.06 earnings per share. Confluent has set its Q3 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.360-0.360 EPS. Research analysts expect that Confluent, Inc. will post -0.83 EPS for the current fiscal year.

Confluent Company Profile

(Free Report)

Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.

Featured Stories

Institutional Ownership by Quarter for Confluent (NASDAQ:CFLT)

Receive News & Ratings for Confluent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Confluent and related companies with MarketBeat.com's FREE daily email newsletter.